OSCR

Transcriptomic profiling and targeted validation reveal molecular mechanisms of oxygen therapy in high-altitude cerebral injury.

Overview

Authors: Xiaojie Hu1,2, Xuedong Bai3, Shuyi Pan1,2, Hang Li1,2
  1. Department of Hyperbaric Oxygen, Sixth Medical Center, Chinese PLA General Hospital, Beijing, China
  2. School of Medicine, South China University of Technology, Guangzhou, China
  3. Department of Orthopedics, Sixth Medical Center, Chinese PLA General Hospital, Beijing, China
Journal: Frontiers in neuroscience, volume 20, article 1738756
Dates: received 3 November 2025; accepted 27 March 2026; published online 13 April 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.3389/fnins.2026.1738756 · PMID 42051552 · PMCID PMC13111426 · OpenAlex W7154188021
Open access: gold, a free copy (OpenAlex)
Categories: genetics / omics (modality), histology / microscopy (modality), mouse (organism), cellular / molecular (subfield)
Methods: Statistics
Keywords: high-altitude cerebral injury, hyperbaric oxygen, neuroinflammation, oxidative stress, PI3K–AKT pathway, TLR4–NF-κB pathway, transcriptomics
Topic: High Altitude and Hypoxia (Physiology (medical), Medicine), according to OpenAlex
Citations: not cited yet (Europe PMC); 38 references in the paper

Abstract

Background: Exposure to high-altitude hypoxia is associated with an increased risk of impaired brain structure and function, with oxidative stress and neuroinflammation widely recognized as key mechanisms involved. In this context, hyperbaric oxygen therapy is considered a potential intervention; however, the mechanism by which it affects cerebral function changes caused by high-altitude exposure remains to be further elucidated.

Objective: This study aims to explore and compare the therapeutic effects of normobaric oxygen (NBO) and hyperbaric oxygen (HBO) on high-altitude cerebral injury (HACI), and to elucidate the molecular mechanisms underlying their neuroprotective effects using transcriptomic profiling and targeted validation.

Methods: A mouse model of high-altitude cerebral injury was established using a hypobaric hypoxia chamber. Mice were exposed to a simulated altitude of 7,000 m (approximately 9.8% O₂ at 0.47 ATA) for 3 consecutive days to induce severe hypoxia. Animals were divided into four groups: Control (Con), High-Altitude exposure (HH), post-HH treated with normobaric oxygen (NBO; 100% O₂ at 1.0 ATA for 1 h daily for 3 days), and post-HH treated with hyperbaric oxygen (HBO; 100% O₂ at 2.0 ATA for 1 h daily for 3 days). Brain tissues were analyzed using H&E staining, RNA sequencing (RNA-seq), Western blotting for key pathway proteins, immunofluorescence for glial cell activation, and ELISA for inflammatory cytokines. Oxidative stress markers (SOD, MDA, GSH, NO) were also assessed.

Results: Histopathological analysis confirmed cerebral damage in the HH group, which was significantly ameliorated by both HBO and NBO treatments. RNA-seq revealed widespread disruption of the cerebral transcriptome following high-altitude exposure. Oxygen therapy was associated with partial restoration of global gene expression patterns. KEGG pathway analysis highlighted significant enrichment in pathways related to NF-κB signaling, cytokine–cytokine receptor interaction, IL-17 signaling, and PI3K–AKT signaling. Subsequent targeted validation demonstrated that oxygen treatment reduced oxidative stress (increased SOD and GSH; decreased MDA and NO) and modulated the PI3K–AKT signaling pathway (increased p-AKT/AKT). Concurrently, oxygen therapy attenuated neuroinflammatory responses, inhibiting microglial and astrocytic activation, reducing pro-inflammatory cytokine levels (IL-1β, IL-6, TNF-α), and modulating the TLR4–NF-κB signaling axis (decreased TLR4 and p-p65/p65). HBO treatment was associated with broader modulation of several molecular pathways involved in oxidative stress and inflammation.

Conclusion: Existing evidence suggests that HBO may exert protective effects against altitude-related brain injury. This mechanism likely involves activating the PI3K–AKT/Nrf2 axis to alleviate oxidative stress and inhibiting the TLR4–NF-κB pathway to reduce neuroinflammation, thereby partially restoring transcriptional homeostasis. However, the causal relationships between these pathways and their interactions require further validation and refinement.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data availability statement

The raw RNA-seq data generated in this study have been deposited in the NCBI Sequence Read Archive (SRA, submission ID: SUB16095504) and are associated with the BioProject: PRJNA1447108. The public URL for the project is: https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1447108.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 29 September 2026: the first record

Recorded: type, language, journal, volume, pages, dates, 4 authors, 7 keywords, 38 references.

Cite

This paper

Hu, X., Bai, X., Pan, S., & Li, H. (2026). Transcriptomic profiling and targeted validation reveal molecular mechanisms of oxygen therapy in high-altitude cerebral injury. Frontiers in neuroscience, 20, 1738756. https://doi.org/10.3389/fnins.2026.1738756

BibTeX

@article{hu2026transcriptomic,
author = {Hu, Xiaojie and Bai, Xuedong and Pan, Shuyi and Li, Hang},
title = {{Transcriptomic profiling and targeted validation reveal molecular mechanisms of oxygen therapy in high-altitude cerebral injury}},
journal = {Frontiers in neuroscience},
year = {2026},
month = apr,
volume = {20},
pages = {1738756},
publisher = {Frontiers Media SA},
issn = {1662-4548},
doi = {10.3389/fnins.2026.1738756},
url = {https://doi.org/10.3389/fnins.2026.1738756},
pmid = {42051552},
pmcid = {PMC13111426}
}

RIS

TY - JOUR
AU - Hu, Xiaojie
AU - Bai, Xuedong
AU - Pan, Shuyi
AU - Li, Hang
TI - Transcriptomic profiling and targeted validation reveal molecular mechanisms of oxygen therapy in high-altitude cerebral injury
T2 - Frontiers in neuroscience
J2 - Front Neurosci
PY - 2026
DA - 2026/04/13
VL - 20
SP - 1738756
SN - 1662-4548
PB - Frontiers Media SA
DO - 10.3389/fnins.2026.1738756
UR - https://doi.org/10.3389/fnins.2026.1738756
LA - en
ER -

CSL-JSON

{
"id": "10.3389/fnins.2026.1738756",
"type": "article-journal",
"title": "Transcriptomic profiling and targeted validation reveal molecular mechanisms of oxygen therapy in high-altitude cerebral injury",
"container-title": "Frontiers in neuroscience",
"author": [
{
"family": "Hu",
"given": "Xiaojie"
},
{
"family": "Bai",
"given": "Xuedong"
},
{
"family": "Pan",
"given": "Shuyi"
},
{
"family": "Li",
"given": "Hang"
}
],
"container-title-short": "Front Neurosci",
"volume": "20",
"page": "1738756",
"DOI": "10.3389/fnins.2026.1738756",
"PMID": "42051552",
"PMCID": "PMC13111426",
"ISSN": "1662-4548",
"publisher": "Frontiers Media SA",
"URL": "https://doi.org/10.3389/fnins.2026.1738756",
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
13
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.3389/fimmu.2026.1852083
Astrocyte-derived HMGB1 compromises the integrity of the blood-brain barrier through the CaM/CaMKII/AQP4 pathway and the protective function of trifluoperazine.
Journal: Frontiers in immunology
In common: mouse, cellular / molecular, 2 references
[2] doi:10.3390/cells12101418 [code]
LPS-Induced Systemic Inflammation Affects the Dynamic Interactions of Astrocytes and Microglia with the Vasculature of the Mouse Brain Cortex.
Journal: Cells
In common: mouse, cellular / molecular, 2 references
[3] doi:10.1016/j.xpro.2023.102775
Protocol for measuring protein synthesis in specific cell types in the mouse brain using in vivo non-canonical amino acid tagging.
Journal: STAR protocols
In common: histology / microscopy, mouse, cellular / molecular, 1 reference
[4] doi:10.1016/j.xpro.2022.101837 [code]
Sparse postnatal labeling and quantification of superficial cortical cell synapses in the mouse neocortex.
Journal: STAR protocols
In common: histology / microscopy, mouse, cellular / molecular, 1 reference
[5] doi:10.1016/j.xpro.2023.102707
A pipeline for STED super-resolution imaging and Imaris analysis of nanoscale synapse organization in mouse cortical brain slices.
Journal: STAR protocols
In common: histology / microscopy, mouse, 1 reference
[6] doi:10.3389/fimmu.2025.1616312
Identifying pyroptosis-hub genes and immune infiltration in neonatal hypoxic-ischemic brain injury.
Journal: Frontiers in immunology
In common: genetics / omics, cellular / molecular, 1 reference
[7] doi:10.3390/antiox13101274
Integrative Human Genetic and Cellular Analysis of the Pathophysiological Roles of AnxA2 in Alzheimer's Disease.
Journal: Antioxidants (Basel, Switzerland)
In common: genetics / omics, cellular / molecular, 1 reference
[8] doi:10.1186/s12964-025-02420-8
BMAL1 modulation alleviates inflammatory responses in monocytes by targeting the Fis1-mediated mitochondrial unfolded protein response in high-altitude hypoxia.
Journal: Cell communication and signaling : CCS
In common: mouse, cellular / molecular, 1 reference
[9] doi:10.3389/fphar.2023.1197433
Zhilong Huoxue Tongyu capsule attenuates intracerebral hemorrhage induced redox imbalance by modulation of Nrf2 signaling pathway.
Journal: Frontiers in pharmacology
In common: mouse, cellular / molecular, 1 reference
[10] doi:10.1111/ene.15360
The contribution of neuropathology to multiple sclerosis research.
Journal: European journal of neurology
In common: histology / microscopy, cellular / molecular, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.